Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieven Pouillon

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2018
Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational studyLieven Pouillon, Anne Lamoureux, Guillaume Pineton de Chambrun, et al.
Inflammatory Bowel Diseases|March 30, 2021
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel DiseasesClaire Liefferinckx, Jérémie Bottieau, Jean-François Toubeau, et al.
United European Gastroenterology Journal|May 7, 2021
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.
Journal of Crohn'S & Colitis|June 7, 2020
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis HistopathologyFernando Magro, Glen Doherty, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR IndexMarion Schaefer, Valérie Laurent, Aurélie Grandmougin, et al.
Journal of Clinical Medicine|September 27, 2025
Ustekinumab in Ulcerative Colitis: A Real-Life Effectiveness Study Across Multiple Belgian Centers (SULTAN)Tom Holvoet, Marie Truyens, Catherine Reenaers, et al.
Alimentary Pharmacology & Therapeutics|April 2, 2019
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patientsLieven Pouillon, Silvio Danese, Ailsa Hart, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter StudyMathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2024
Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for FutilityClara Caenepeel, Sara Deleu, Jorge Francisco Vazquez Castellanos, et al.
Gastroenterology|August 8, 2022
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled TrialMarie Truyens, Triana Lobatón, Marc Ferrante, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2018
Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational studyLieven Pouillon, Anne Lamoureux, Guillaume Pineton de Chambrun, et al.
Inflammatory Bowel Diseases|March 30, 2021
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel DiseasesClaire Liefferinckx, Jérémie Bottieau, Jean-François Toubeau, et al.
United European Gastroenterology Journal|May 7, 2021
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.
Journal of Crohn'S & Colitis|June 7, 2020
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis HistopathologyFernando Magro, Glen Doherty, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR IndexMarion Schaefer, Valérie Laurent, Aurélie Grandmougin, et al.
Journal of Clinical Medicine|September 27, 2025
Ustekinumab in Ulcerative Colitis: A Real-Life Effectiveness Study Across Multiple Belgian Centers (SULTAN)Tom Holvoet, Marie Truyens, Catherine Reenaers, et al.
Alimentary Pharmacology & Therapeutics|April 2, 2019
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patientsLieven Pouillon, Silvio Danese, Ailsa Hart, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter StudyMathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2024
Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for FutilityClara Caenepeel, Sara Deleu, Jorge Francisco Vazquez Castellanos, et al.
Gastroenterology|August 8, 2022
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled TrialMarie Truyens, Triana Lobatón, Marc Ferrante, et al.
Pageof 6